Follow NWC SCN and Senate on Twitter

Cheshire & Merseyside Chemotherapy Protocols

Funding

It is the responsibility of each individual provider to ensure they have the necessary funding arrangements in place before using any of the CMSCN treatment protocols.

Dose Modifications

A number of the following treatment protocols have used the UCLH (Dosage Adjustment for Cytotoxics in Hepatic & Renal Impairment) documents for any recommeded dose modifications.


Solid tumour chemotherapy protocols (on the CCO site) 

 

Acute Lymphoblastic Leukaemia (ALL)

Acute Myeloid Leukaemia (AML)

Hodgkin’s Lymphoma (HL)

Chronic Lymphocytic Leukaemia (CLL)

Chronic Myeloid Leukaemia (CML)

Follicular and Nodal Marginal Zone Lymphomas (FL & MZL)

Diffuse Large B cell Lymphoma (DLBCL)

Burkitt’s Lymphoma (BL)

Myeloproliferative Neoplasms (MPN)

Mantle Cell Lymphoma (MCL)

Myelodysplastic Syndromes (MDS)

Primary Central Nervous System Lymphoma (PCNSL) and Primary Intraocular lymphoma (PIOL)

Multiple Myeloma (MM)

Waldenström's Macroglobulinemia (WM)

Salvage Chemotherapy